Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,343 | -4,674 | -2,105 | -53,595 | -43,026 |
| Depreciation Amortization | 23 | 20 | 11 | 1,145 | 901 |
| Accounts payable and accrued liabilities | 954 | 103 | -42 | -13,029 | -11,749 |
| Other Working Capital | 831 | 95 | -140 | -2,711 | -8,101 |
| Other Operating Activity | -822 | -15 | 90 | 30,251 | 25,353 |
| Operating Cash Flow | $-6,357 | $-4,471 | $-2,186 | $-37,939 | $-36,622 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 117 | 111 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $117 | $111 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -167 | N/A |
| Common Stock Issued | N/A | N/A | N/A | 294 | 269 |
| Common Stock Repurchased | N/A | N/A | N/A | -275 | -267 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -138 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $-148 | $-136 |
| Beginning Cash Position | 14,022 | 14,022 | 14,022 | 158,708 | 158,708 |
| End Cash Position | 7,665 | 9,551 | 11,836 | 120,738 | 122,061 |
| Net Cash Flow | $-6,357 | $-4,471 | $-2,186 | $-37,970 | $-36,647 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,357 | -4,471 | -2,186 | -37,939 | -36,622 |
| Capital Expenditure | N/A | N/A | N/A | -7 | -7 |
| Free Cash Flow | -6,357 | -4,471 | -2,186 | -37,946 | -36,629 |